Ikena Oncology, Inc.

IKNACIK 0001835579 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K filed Mar 10, 2026. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone -0.0181

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

May 7, 2026no items parsed Apr 13, 2026no items parsed Mar 17, 2026no items parsed Mar 10, 2026no items parsed Feb 17, 2026no items parsed

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Ikena Oncology, Inc.

Name	Roles	Filings
Yarema Kristin	OfficerDirector	2
Germa Caroline	Officer	1
Lu Yufang	Officer	1
Renaud Ronald C Jr	Director	1

Showing 21-24 of 24

Per pagePrevPage 5 of 5

All filings

62 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Dec 22, 2025	Slattery Joseph P Director	Holdings only	-	-	-
Dec 22, 2025	Wang Jonathan Jian Director	Holdings only	-	-	-
Dec 22, 2025	Wang Stephen Hui Director	Holdings only	-	-	-
Oct 10, 2025	Wang Stephen Hui Director	AGrant	188,042	-	-
Aug 15, 2025	Wang Jonathan Jian Director	AGrant	143,832	-	-

Showing 6-10 of 62

Per pagePrevPage 2 of 13Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value